Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.
Identifieur interne : 000048 ( PubMed/Checkpoint ); précédent : 000047; suivant : 000049Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.
Auteurs : Julia Stowe [Royaume-Uni] ; Nick Andrews [Royaume-Uni] ; Elizabeth Miller [Royaume-Uni]Source :
- CNS drugs [ 1179-1934 ] ; 2020.
Abstract
This article evaluates the epidemiological evidence for a relationship between vaccination and neurological disease, specifically multiple sclerosis, Guillain-Barré syndrome and narcolepsy. The statistical methods used to test vaccine safety hypotheses are described and the merits of different study designs evaluated; these include the cohort, case-control, case-coverage and the self-controlled case-series methods. For multiple sclerosis, the evidence does not support the hypothesized relationship with hepatitis B vaccine. For Guillain-Barré syndrome, the evidence suggests a small elevated risk after influenza vaccines, though considerably lower than after natural influenza infection, with no elevated risk after human papilloma virus vaccine. For narcolepsy, there is strong evidence of a causal association with one adjuvanted vaccine used in the 2009/10 influenza pandemic. Rapid investigation of vaccine safety concerns, however biologically implausible, is essential to maintain public and professional confidence in vaccination programmes.
DOI: 10.1007/s40263-019-00670-y
PubMed: 31576507
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:31576507Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.</title><author><name sortKey="Stowe, Julia" sort="Stowe, Julia" uniqKey="Stowe J" first="Julia" last="Stowe">Julia Stowe</name><affiliation wicri:level="1"><nlm:affiliation>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK. Julia.stowe@phe.gov.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ</wicri:regionArea><wicri:noRegion>NW9 5EQ</wicri:noRegion></affiliation></author><author><name sortKey="Andrews, Nick" sort="Andrews, Nick" uniqKey="Andrews N" first="Nick" last="Andrews">Nick Andrews</name><affiliation wicri:level="1"><nlm:affiliation>Statistics and Modelling Economics Unit, Public Health England, London, NW9 5EQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Statistics and Modelling Economics Unit, Public Health England, London, NW9 5EQ</wicri:regionArea><wicri:noRegion>NW9 5EQ</wicri:noRegion></affiliation></author><author><name sortKey="Miller, Elizabeth" sort="Miller, Elizabeth" uniqKey="Miller E" first="Elizabeth" last="Miller">Elizabeth Miller</name><affiliation wicri:level="1"><nlm:affiliation>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ</wicri:regionArea><wicri:noRegion>NW9 5EQ</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:31576507</idno><idno type="pmid">31576507</idno><idno type="doi">10.1007/s40263-019-00670-y</idno><idno type="wicri:Area/PubMed/Corpus">000090</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000090</idno><idno type="wicri:Area/PubMed/Curation">000090</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000090</idno><idno type="wicri:Area/PubMed/Checkpoint">000048</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000048</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.</title><author><name sortKey="Stowe, Julia" sort="Stowe, Julia" uniqKey="Stowe J" first="Julia" last="Stowe">Julia Stowe</name><affiliation wicri:level="1"><nlm:affiliation>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK. Julia.stowe@phe.gov.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ</wicri:regionArea><wicri:noRegion>NW9 5EQ</wicri:noRegion></affiliation></author><author><name sortKey="Andrews, Nick" sort="Andrews, Nick" uniqKey="Andrews N" first="Nick" last="Andrews">Nick Andrews</name><affiliation wicri:level="1"><nlm:affiliation>Statistics and Modelling Economics Unit, Public Health England, London, NW9 5EQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Statistics and Modelling Economics Unit, Public Health England, London, NW9 5EQ</wicri:regionArea><wicri:noRegion>NW9 5EQ</wicri:noRegion></affiliation></author><author><name sortKey="Miller, Elizabeth" sort="Miller, Elizabeth" uniqKey="Miller E" first="Elizabeth" last="Miller">Elizabeth Miller</name><affiliation wicri:level="1"><nlm:affiliation>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ</wicri:regionArea><wicri:noRegion>NW9 5EQ</wicri:noRegion></affiliation></author></analytic><series><title level="j">CNS drugs</title><idno type="eISSN">1179-1934</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This article evaluates the epidemiological evidence for a relationship between vaccination and neurological disease, specifically multiple sclerosis, Guillain-Barré syndrome and narcolepsy. The statistical methods used to test vaccine safety hypotheses are described and the merits of different study designs evaluated; these include the cohort, case-control, case-coverage and the self-controlled case-series methods. For multiple sclerosis, the evidence does not support the hypothesized relationship with hepatitis B vaccine. For Guillain-Barré syndrome, the evidence suggests a small elevated risk after influenza vaccines, though considerably lower than after natural influenza infection, with no elevated risk after human papilloma virus vaccine. For narcolepsy, there is strong evidence of a causal association with one adjuvanted vaccine used in the 2009/10 influenza pandemic. Rapid investigation of vaccine safety concerns, however biologically implausible, is essential to maintain public and professional confidence in vaccination programmes.</div></front></TEI><pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">31576507</PMID><DateRevised><Year>2020</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1934</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>CNS drugs</Title><ISOAbbreviation>CNS Drugs</ISOAbbreviation></Journal><ArticleTitle>Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.</ArticleTitle><Pagination><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40263-019-00670-y</ELocationID><Abstract><AbstractText>This article evaluates the epidemiological evidence for a relationship between vaccination and neurological disease, specifically multiple sclerosis, Guillain-Barré syndrome and narcolepsy. The statistical methods used to test vaccine safety hypotheses are described and the merits of different study designs evaluated; these include the cohort, case-control, case-coverage and the self-controlled case-series methods. For multiple sclerosis, the evidence does not support the hypothesized relationship with hepatitis B vaccine. For Guillain-Barré syndrome, the evidence suggests a small elevated risk after influenza vaccines, though considerably lower than after natural influenza infection, with no elevated risk after human papilloma virus vaccine. For narcolepsy, there is strong evidence of a causal association with one adjuvanted vaccine used in the 2009/10 influenza pandemic. Rapid investigation of vaccine safety concerns, however biologically implausible, is essential to maintain public and professional confidence in vaccination programmes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stowe</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK. Julia.stowe@phe.gov.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Statistics and Modelling Economics Unit, Public Health England, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Immunisation and Countermeasures, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>CNS Drugs</MedlineTA><NlmUniqueID>9431220</NlmUniqueID><ISSNLinking>1172-7047</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31576507</ArticleId><ArticleId IdType="doi">10.1007/s40263-019-00670-y</ArticleId><ArticleId IdType="pii">10.1007/s40263-019-00670-y</ArticleId><ArticleId IdType="pmc">PMC7224038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 1993 Apr 17;341(8851):979-82</Citation><ArticleIdList><ArticleId IdType="pubmed">8096942</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2004 May 7;22(15-16):2064-70</Citation><ArticleIdList><ArticleId IdType="pubmed">15121324</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 1993 Aug;22(4):742-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8225751</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2004 Sep 14;63(5):838-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15365133</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2018 Mar 14;36(12):1548-1555</Citation><ArticleIdList><ArticleId IdType="pubmed">29454521</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1979 Aug;110(2):105-23</Citation><ArticleIdList><ArticleId IdType="pubmed">463869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleep Med Rev. 2018 Apr;38:177-186</Citation><ArticleIdList><ArticleId IdType="pubmed">28847694</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2015 Jul 17;33(31):3773-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25999283</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2001 Mar;84(3):227-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11207170</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2001 Oct 15;20 Suppl 1:S49-53; discussion S45-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11587812</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7 Suppl 2:S7-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12142932</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2014 Feb;275(2):172-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24134219</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e33723</Citation><ArticleIdList><ArticleId IdType="pubmed">22470463</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2006 Oct;5(5):641-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17181438</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2002 Dec;87(6):493-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12456546</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2015 Jun 23;2(8):891-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26425696</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Sep 13;31(40):4448-58</Citation><ArticleIdList><ArticleId IdType="pubmed">23770307</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Oct 19;29(45):7878-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21875631</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e33536</Citation><ArticleIdList><ArticleId IdType="pubmed">22470453</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2003 Sep 8;21(25-26):4003-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12922137</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 Apr 27;381(9876):1461-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23498095</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2009 Feb 1;169(3):382-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19033158</ArticleId></ArticleIdList></Reference><Reference><Citation>Postgrad Med J. 2000 Dec;76(902):774-82</Citation><ArticleIdList><ArticleId IdType="pubmed">11085768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleep. 2016 May 01;39(5):1051-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26856903</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Mar 23;35(13):1729-1732</Citation><ArticleIdList><ArticleId IdType="pubmed">28245941</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2013 Feb 26;346:f794</Citation><ArticleIdList><ArticleId IdType="pubmed">23444425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1999 Jun 12;353(9169):2026-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10376617</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 2003 Jan;55(1):107-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12534647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2004 Sep;114(3):584-91</Citation><ArticleIdList><ArticleId IdType="pubmed">15342825</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jul 12;34(32):3684-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27286641</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2016 Oct;12:295-301</Citation><ArticleIdList><ArticleId IdType="pubmed">27658738</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2007 Mar 15;165(6):704-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17204517</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2001 Apr;20(4):410-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11332666</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2013 Sep 19;18(38):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24084340</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2005 Mar;90(3):292-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15723921</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2013 Nov;57(10):1427-34</Citation><ArticleIdList><ArticleId IdType="pubmed">23964090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Stowe, Julia" sort="Stowe, Julia" uniqKey="Stowe J" first="Julia" last="Stowe">Julia Stowe</name></noRegion><name sortKey="Andrews, Nick" sort="Andrews, Nick" uniqKey="Andrews N" first="Nick" last="Andrews">Nick Andrews</name><name sortKey="Miller, Elizabeth" sort="Miller, Elizabeth" uniqKey="Miller E" first="Elizabeth" last="Miller">Elizabeth Miller</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000048 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000048 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:31576507
|texte= Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:31576507" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |